T he development and maintenance of B lymphocytes is regulated at multiple checkpoints (1). Newly generated pro-B cells undergo B cell antigen-receptor (BCR) recombination in fetal liver and adult bone marrow (BM). B cells that fail to produce a functional BCR lack survival signals and thus undergo death by neglect (2). B cells that express surface BCRs that interact with self-antigens with too high affinity may be eliminated, at least in part, by apoptotic cell death, as well as anergy and receptor editing (3, 4). Immature B cells that successfully pass through developmental checkpoints in the BM migrate to the spleen as transitional B cells and undergo further maturation steps (5). The number of B lymphocytes in BM and secondary lymphoid organs is kept under tight control. Disruption of this homeostasis and accumulation of excess lymphocytes may give rise to the development of autoimmunity or malignancy.
T he development and maintenance of B lymphocytes is regulated at multiple checkpoints (1) . Newly generated pro-B cells undergo B cell antigen-receptor (BCR) recombination in fetal liver and adult bone marrow (BM). B cells that fail to produce a functional BCR lack survival signals and thus undergo death by neglect (2) . B cells that express surface BCRs that interact with self-antigens with too high affinity may be eliminated, at least in part, by apoptotic cell death, as well as anergy and receptor editing (3, 4) . Immature B cells that successfully pass through developmental checkpoints in the BM migrate to the spleen as transitional B cells and undergo further maturation steps (5) . The number of B lymphocytes in BM and secondary lymphoid organs is kept under tight control. Disruption of this homeostasis and accumulation of excess lymphocytes may give rise to the development of autoimmunity or malignancy.
BCL-2 family member proteins are requisite for the maintenance of lymphocyte numbers by regulating an intrinsic apoptosis pathway (2, (6) (7) (8) . The antiapoptotic members, including BCL-2, BCL-xL, and MCL-1, display sequence conservation in four BCL-2 homology domains (BH1-BH4). Multidomain proapoptotic members, including BAX and BAK, possess the BH1, BH2, and BH3 domains. The ''BH3-only'' proteins, including BID, BAD, BIM, NOXA, and PUMA, show homology only within this single amphipathic ␣-helical segment. BH3-only molecules function as upstream sentinels that sense cellular abnormalities, such as lack of survival signals or DNA damage. Activated BH3-only molecules trigger the oligomerization of multidomain proapoptotic BCL-2 members by sequestering antiapoptotics and͞or by direct activation of BAX or BAK (9) (10) (11) (12) . Oligomerization of BAX or BAK leads to the release of cytochrome c from mitochondria to the cytoplasm, causing the formation of the apoptosome and execution of cell death.
The role of the BCL-2 family in B cell homeostasis has been analyzed intensively by using mouse models that either have overexpression or deletion of BCL-2 family molecules (2, (13) (14) (15) . Overexpression of BCL-2 protects B cells from death by neglect and by negative selection, and causes the accumulation of B cells (13, 16, 17) . In addition, lymphocytes from Bcl-2 transgenic mice show defects in cell cycle progression (18, 19) . In contrast, targeted deletion of the Bcl-2 gene in mice resulted in the massive loss of mature lymphocytes due to apoptosis, as well as increased turnover of thymocytes (15, 20) . Deletion of another antiapoptotic, MCL-1, resulted in the loss of B cells throughout their development (21) . Among BH3 only molecules, only BIM is implicated in the homeostatic maintenance of lymphocytes. Bim-deficient mice are reported to show abnormal development of T lymphocytes and accumulation of lymphocytes in secondary lymphoid organs (20, 22) . Bim Ϫ/Ϫ B cells were resistant to apoptosis induced by the absence of IL-7 receptor signaling and by BCR ligation, and showed defective negative selection of B cells in vivo (23, 24) . In addition, Bim Ϫ/Ϫ mice develop autoimmune kidney disease (22) . However, it is still unclear whether this single BH3-only molecule functions as the sole regulator of lymphocyte number.
Mice deficient in either Bax or Bak showed minimal phenotype in lymphocytes except mild lymphoadenopathy reported in Baxdeficient mice (25) . Deficiency in both Bax and Bak causes embryonic lethality in most cases. The surviving doubly deficient mice display lymphocyte abnormalities, including increased numbers of splenocytes and resistance of splenocytes and thymocytes to apoptotic stimuli (26) . Mouse embryonic fibroblasts (MEFs) deficient for both Bax and Bak (Bax Ϫ/Ϫ Bak Ϫ/Ϫ ) are highly resistant to induction of apoptosis by multiple intrinsic death stimuli and by the enforced expression of BH3-only molecules (9, 10, 26, 27 Immunohistochemistry. Frozen 6-m sections were fixed in acetone and stained with rat anti-MOMA-1 (Cedarlane Laboratories), followed by alkaline phosphatase-conjugated streptavidin. The sections were subsequently stained with biotinylated rat anti-CD19 (Pharmingen) followed with horseradish peroxidase-conjugated goat anti-rat IgG. Generation of Bim Null Mice. To generate mice completely null for Bim, we adopted a targeting strategy different from that reported by Bouillet et al. (22) . Newly targeted mice in which the first 4 exons of the Bim gene are deleted by homologous recombination of ES cells were generated to ensure the lack of any aberrant BIM protein (Fig. 7 , which is published as supporting information on the PNAS web site); this was especially important because the Bim-targeted mice generated by Bouillet et al. were reported to still express an aberrant BIM protein without a BH3 domain, raising the possibility that this partial protein may have affected the phenotype of these mice. (Fig. 1D) . The Ig concentrations of Bim Ϫ/Ϫ mice were also increased, in agreement with previous reports (data not shown) (22) . These results indicate that, in the absence of BAX and BAK, the elevated number of B cells correlates with abnormal production of Ig. (Fig. 2A) . Next, we examined whether BAX and BAK is involved in the negative selection of B cells. Immature B cells are known to undergo apoptosis after BCR crosslinking, and this system has been used as an in vitro model for negative selection. Immature BM (B220 ϩ IgM ϩ ) B cells and immature splenic (IgM high IgD low ) B cells were sorted from control and mutant mice and stimulated with increasing concentrations of anti-IgM F(abЈ) 2 fragment. Control B cells died after 18 h of culture in response to BCR ligation in a dose-dependent manner (Fig. 2B) . In contrast, B cells from CD19Cre ϩ Bax fl/Ϫ Bak Ϫ/Ϫ mice were viable after stimulation with up to 50 g͞ml anti-IgM F(abЈ) 2 fragment. Immature B cells from Bim Ϫ/Ϫ mice were also highly resistant to induction of cell death in response to BCR crosslinking, consistent with previous reports.
Increased Abundance of B Cells in
We next examined the role of BAX, BAK, and BIM in the cell death pathway of various apoptosis stimuli in mature splenic B cells. Purified B cells from spleens were cultured either without cytokines, in the presence of dexamethasone or VP-16, or after ␥-irradiation. Bax-and Bak-deficient splenic B cells were dramatically resistant to all of these death stimuli, consistent with enhanced accumulation of B cells in these mice (Fig. 2C) . Bim Ϫ/Ϫ mature splenic B cells showed only partial viability relative to control and CD19Cre ϩ Bax fl/Ϫ Bak Ϫ/Ϫ cells. Bim deficiency afforded enhanced survival for only the short term when cells were cultured in the absence of cytokines or in the presence of dexamethasone; it was not sufficient to block death after 7-9 days of culture without cytokines or 2 days after dexamethasone. Furthermore, Bim (Fig. 3A) .
DNA synthesis after mitogen stimulation was also analyzed by pulsing the cells with BrdUrd and intracellular staining with anti-BrdUrd Ab. Cells from CD19Cre ϩ Bax fl/Ϫ Bak Ϫ/Ϫ mice showed defective incorporation of BrdUrd in response to LPS and anti-IgM Ab, but not to CpG-DNA (Fig. 3B) . In contrast, BrdUrd incorporation upon mitogen stimulation was not impaired in B cells from control mice deficient in either BAX or BAK alone (data not shown). These results indicate that BAX and BAK deficiency, but not BIM deficiency, strongly effects cell cycle regulation by inhibiting S phase entry.
To further dissect the defect in cell cycle progression, we measured the expression of the cyclin-dependent kinase (cdk) inhibitor p27 protein with time after stimulation with either CpG-DNA or LPS. p27 protein was down-regulated 12 h after CpG-DNA stimulation in control and CD19Cre ϩ Bax fl/Ϫ Bak Ϫ/Ϫ B cells (Fig.  4C) . In response to LPS, however, p27 expression was reduced in control but not LPS and CpG-DNA are recognized by TLR4 and TLR9, respectively (34) . Signaling pathways emanating from both TLR4 and TLR9 are thought to share most signaling molecules resulting in the activation of the transcription factor NF-B and mitogen-activated protein kinases (34) . However, the response of B cells to LPS has been shown to require another member of the TLR family, RP105 (CD180), in addition to TLR4 (35) . To analyze the mechanism for the differential cell cycling response observed in CD19Cre ϩ -Bax fl/Ϫ Bak Ϫ/Ϫ B cells, the signaling pathways that participate in LPS and CpG-DNA were examined. Several parameters indicated that the canonical signaling pathway leading to NFB-induced gene expression is not affected by Bax and Bak-deficiency. These include comparable activation of IB degradation (Fig. 4A) , NFB DNAbinding (Fig. 4B) , and normal c-myc induction (Fig. 4C) .
Because LPS utilizes RP105 as a receptor in addition to TLR4, we tested whether B cell proliferation induced by an anti-RP105 stimulating Ab was affected. The cell cycle progression in response to anti-RP105 Ab was also impaired (Fig. 3B) , suggesting that the impaired RP105 signaling is partly involved in the impaired responsiveness against LPS in Bax and Bak deficiency. (Fig. 5C ). Histological analysis of sick mice showed that the MxCre ϩ Bax fl/Ϫ Bak Ϫ/Ϫ mice had severe glomeluronephritis and arthritis (Fig. 5D) . These results indicate that BAX and BAK play a critical role in preventing the development of autoimmune disease.
Discussion
In this study, we used a conditional BAX͞BAK-deficient mouse model as a valuable tool to demonstrate that the proapoptotic BCL-2 family members BAX and BAK are essential for controlling the numbers of both BM and splenic B cells. B cells prepared from B cell-specific Bax-and Bak-deficient mice are highly resistant to multiple cell death stimuli, including cytokine withdrawal, BCR crosslinking, steroid treatment, and DNA damage. This finding is consistent with previous observations showing extensive resistance of Bax Ϫ/Ϫ Bak Ϫ/Ϫ mouse embryonic fibroblasts to intrinsic apoptotic stimuli. Although a previous report showed that Bim Ϫ/Ϫ B cells have partial resistance to BCR crosslinking, B cells from CD19Cre ϩ -Bax fl/Ϫ Bak Ϫ/Ϫ mice showed almost complete survival, clarifying that BCR-induced cell death is mediated fully by the intrinsic cell death pathway. Our results clearly show that BAX and BAK is the exclusive gateway for intrinsic cell death in B cells. Here we show that Bax and Bak deficiency resulted in a dramatic increase in the number of B cells at all stages of development in the BM and spleen. This phenotype is consistent with previous studies showing increased abundance of lymphocytes and the resistance of cells to apoptotic stimuli in the few mice that survive Bax and Bak deficiency to adulthood (26) .
The increase of splenic B cell was reflected in transitional and mature follicular B cells. Interestingly, however, the number of MZ B cells and B-1 cells was not increased. Both follicular and MZ B cells are differentiated from immature B cells supplied from BM; however, the precise mechanism of their differentiation from transitional B cell populations is still controversial (36) . Our study implies that apoptosis may play an important role in controlling the abundance of follicular, but not MZ, B cells. It is suggested that follicular B cells turnover more rapidly than MZ B cells (37) . Homeostatic proliferation is implicated in the maintenance of MZ B cell pool. Therefore, the regulation of cell cycle progression by BAX and BAK may affect the generation of MZ B cells. The role of BAX and BAK in controlling any of these processes may be differentially involved at particular stages of B cell development. Stage-specific deletion studies will clarify the mechanism how these different B cell subsets are maintained.
The newly generated Bim-deficient mice without any detectable BIM protein expression displayed a similar phenotype to the mice reported previously (20, 22 The defect in cell cycle progression of Bax and Bak deficient B cells in response to LPS and anti-IgM stimulation (Fig. 3) is consistent with that observed in Bcl-2 transgenic mice (18) . Previous reports showed that Bcl-2 overexpressing cells had elevated expression of the cdk inhibitors, p27 and p107, which would account for the inhibition of cell cycle progression (38) . However, our observation that p27 is down-regulated normally after CpG-DNA stimulation indicates that BAX or BAK are not direct regulators of cdk inhibitors, but rather that regulation of p27 is a consequence of impaired upstream signaling pathway(s) in the response to LPS.
Bax-and Bak-deficient B cells displayed normal response to a TLR9 ligand, CpG-DNA, despite the severe defect in cell cycle progression to LPS, a TLR4 ligand. This finding is surprising given the overlapping signaling pathways of these two receptors. The analysis of LPS signaling pathway revealed that the NF-B signaling pathway is intact in B cells from CD19Cre ϩ Bax fl/Ϫ Bak Ϫ/Ϫ mice. The defective response to RP105 stimulation, a coreceptor required in response to LPS, may contribute to the abnormal LPS response. These pathways should be further dissected in future studies.
Interestingly, the inducible deletion of Bax and Bak in adulthood in MxCre ϩ Bax fl/Ϫ Bak Ϫ/Ϫ mice resulted in the development of a severe autoimmune disease. Because ANA and anti-dsDNA Ab are produced in the serum of these mice, Bax and Bak deficiency is responsible not only for the increased production of natural Ig leading to the accumulation of immune complexes, but also the production of autoantibodies. In contrast, neither mortality nor accumulation of autoantibodies was observed in CD19Cre ϩ Bax fl/Ϫ Bak Ϫ/Ϫ mice by 35 weeks of age, suggesting that deficiency of Bax and Bak in cells other than B cells is also required to cause a complex immune disease. This cumulative mortality owing to the development of autoimmune disease is also observed in Bim Ϫ/Ϫ mice and in mice overexpressing Bcl-2 in B cells (13, 14, 22) . The overlapping phenotype of these mutant mice fits with the current model of the function of BCL-2 family members in vivo in immune cells, where BH3-only proteins act as upstream sentinels competing for downstream pro-and antiapoptotic BCL-2 members in response to apoptotic or survival signals, suggesting that stapled BH3 peptides may be a promising therapeutic for autoimmune diseases (11, 39) .
